Novel Treatment Review (NTR) Working Group

The haemophilia treatment landscape is fast evolving, with many new and innovative therapies in the final stages of development or being marketed in Europe. To help our members navigate these changes, the EHC has developed a publication, the Novel Treatment Review (NTR) issued twice a year with the latest therapeutic developments.

The work of the NTR Working Group is supported by Roberta Sadauskaite, EHC Public Policy Lead. 

Read the NTRs on the EHC Academy

content-logo-colorfull
content-logo-colorfull

The EHC NTR Committee is composed of: